| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 61 |
| 1 | ASPIRIN 325 MG | 56 |
| 2 | ASPIRIN 81 MG | 56 |
| 3 | CLOPIDOGREL | 47 |
| 4 | RAMIPRIL | 43 |
| 5 | DARUNAVIR | 26 |
| 6 | RITONAVIR | 26 |
| 7 | ACYCLOVIR | 25 |
| 8 | INSULIN GLARGINE | 25 |
| 9 | LAMIVUDINE | 25 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DARUNAVIR 600 MG | 20 | 0.0032 |
| 1 | ASCORBIC ACID, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, FOLIC ACID, COBALAMIN, BIOTIN, PANTOTHENIC ACID | 2 | 0.0031 |
| 2 | RALTEGRAVIR | 15 | 0.0029 |
| 3 | LIDOCAINE HCL 3% | 1 | 0.0022 |
| 4 | DARUNAVIR | 26 | 0.0017 |
| 5 | ZAFIRLUKAST | 1 | 0.0011 |
| 6 | PHENAZOPYRIDINE | 4 | 0.0011 |
| 7 | LAMIVUDINE | 25 | 0.0010 |
| 8 | SOTALOL HYDROCHLORIDE TABLES AF | 2 | 0.0008 |
| 9 | SOTALOL HYDROCHLORIDE TABLETS AF | 2 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 1 | Protease Inhibitor [EPC] | 26 | 0.0006 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 26 | 0.0005 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 26 | 0.0004 |
| 4 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 4 | 0.0004 |
| 5 | Angiotensin Converting Enzyme Inhibitor [EPC] | 43 | 0.0003 |
| 6 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 7 | Adenosine Receptor Agonist [EPC] | 2 | 0.0003 |
| 8 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 9 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 25 | 0.0002 |